In other countries
The same active substances on other registers, the same brand first.
- ZOLMITRIPTAN FLAS CINFA 2,5 mg COMPRIMIDOS BUCODISPERSABLES EFGSpain · 2,5 mg · comprimido bucodispersable · Laboratorios Cinfa S.A.Same form
- ZOLMITRIPTAN FLAS CINFA 5 mg COMPRIMIDOS BUCODISPERSABLES EFGSpain · 5 mg · comprimido bucodispersable · Laboratorios Cinfa S.A.Same form
- Zolmitriptan Flas Combix 2,5 MG Comprimidos Bucodispersables EfgSpain · 2,500 mg · comprimido bucodispersable · Laboratorios Combix S.L.U.Same form
- Zomig 2,5 mg filmom obložene tableteCroatia · filmom obložena tableta · Grünenthal GmbH, Zieglerstraße 6, Aachen, NjemačkaSame form
- Zomig Rapimelt 2,5 mg raspadljive tablete za ustaCroatia · raspadljiva tableta za usta · Grünenthal GmbH, Zieglerstraße 6, Aachen, NjemačkaSame form
- Zelmykra 2,5 mg raspadljive tablete za ustaCroatia · Raspadljiva tableta za usta · Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, HrvatskaSame form
- HeadzolItaly · Compressa rivestita con film · Lanova Farmaceutici S.R.L.Same form
- Zolmitriptan AurobindoItaly · Compressa rivestita con film · Aurobindo Pharma (Italia) S.R.L.Same form
- Zolmitriptan Aurobindo Pharma ItaliaItaly · Compressa orodispersibile · Aurobindo Pharma (Italia) S.R.L.Same form
- Zolmitriptan Aurobindo Disper 2,5 mg, orodispergeerbare tablettenNetherlands · Orodispergeerbare tablet · Aurobindo Pharma B.V.Same form
- Zolmitriptan Glenmark 2,5 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Glenmark Arzneimittel GmbHSame form
- Zolmitriptan Glenmark 2,5 mg orodispergeerbare tablettenNetherlands · Orodispergeerbare tablet · Glenmark Arzneimittel GmbHSame form
- Trecar®Serbia · 2.5mg · oralna disperzibilna tableta · Hemofarm Ad VRŠAcSame form
- ZOMIG RAPIMELT TABLET 2.5 mgSingapore · 2.5 mg · tablet · DKSH Singapore Pte. LTD.Same form
- ZolmitriptanUnited States · 2.5MG, 5MG · tablet, orally disintegrating · Glenmark Pharms LTDSame form
- ZolmitriptanUnited States · 2.5MG, 5MG · tablet · PLD Acquisitions LLCSame form
- ZomigUnited States · 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · IprSame form
- ZomigBrazil · Grünenthal do Brasil Farmacêutica Ltda.Same substance
- Zomig/Zomig OdBrazil · Astrazeneca do Brasil LtdaSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Zolmitriptan
- Strength
- 2.5 MG
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 7 Jun 2011
- Registration
- DIN 02362996
- Marketing authorisation holder
- Sandoz Canada Incorporated
- ATC code
- N02CC03
- Group
- Nervous system
- Supply
- PRESCRIPTION